medline.ch Gastroenterologie Oesophagus Neoplasie

	FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer? Ann Nucl Med García Megías I, Almeida LS, Calapaquí Terán AK, Pabst KM, Herrmann K, Giammarile F, Delgado Bolton RC. PMID: 40069442 [PubMed - as supplied by publisher]
	Exosome-derived miR-148a-3p protect against tumor proliferation and metastasis of esophageal squamous carcinoma. Oncology Zhang J, Toyozum T, Kano M, Matsumoto Y, Otsuka R, Sekino N, Shiraishi T, Okada K, Kamata T, Iida S, Morishita H, Makino T, Nishioka Y, Yamada M, Uesato M, Hayano K, Nakano A, Matsubara H. PMID: 40068649 [PubMed - as supplied by publisher]
	Epidural analgesia during esophagectomy and esophageal cancer prognosis: A population-based nationwide study in Finland. Acta Anaesthesiol Scand Petäjäkangas PH, Helminen O, Helmiö M, Huhta H, Kallio R, Koivukangas V, Kokkola A, Laine S, Lietzen E, Meriläinen S, Pohjanen VM, Rantanen T, Ristimäki A, Räsänen JV, Saarnio J, Sihvo E, Toikkanen V, Tyrväinen T, Valtola A, Kauppila JH. PMID: 40066779 [PubMed - indexed for MEDLINE]
	Survival benefits of postoperative radiotherapy in esophageal cancer during the immunotherapy era:a retrospective cohort study based on the SEER database and a single-center registry in China. Front Immunol Zhang Q, Zhang T, Gu J, Zhang X, Mao Y, Zhu Y, Zhang J, Wang J, Chen S, Cao Y, Wang M, Wang C. PMID: 40066458 [PubMed - indexed for MEDLINE]
	Unveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma. Front Immunol Zhang J, Jia F, Li C, Song S, Gong A. PMID: 40066443 [PubMed - indexed for MEDLINE]
	Impact of Dietary Behavioural Changes on Prognosis of Postoperative Oesophageal Squamous Cell Carcinoma Patients: A Retrospective Cohort Study. Nurs Open Ji F, Chen Y, Ma Y, Wu H, Wei X, Xu Z, Zhao J. PMID: 40064521 [PubMed - indexed for MEDLINE]
	Prehabilitation Program for Lung and Esophageal Cancers (Boosting Recovery and Activity Through Early Wellness): Protocol for a Nonrandomized Trial. JMIR Res Protoc Langley JE, Sibley D, Chiekwe J, Keats MR, Snow S, Purcell J, Sollows S, Hill L, Watton D, Gaudry AE, Hashish I, Wallace A. PMID: 40063931 [PubMed - indexed for MEDLINE]
	A standardized protocol for robot-assisted minimally invasive esophagectomy: improving efficiency and reducing costs. J Robot Surg Kitagami H, Poudel S, Kitayama Y, Koinuma J, Ebihara Y, Hirano S. PMID: 40063141 [PubMed - indexed for MEDLINE]
	[Perioperative chemotherapy or neoadjuvant chemoradiotherapy in the multimodal treatment of esophageal cancer-Results of the ESOPEC trial]. Chirurgie (Heidelb) Schiffmann LM, Bruns CJ. PMID: 40063095 [PubMed - as supplied by publisher]
	Cell-based Immunotherapy in Esophageal Cancer. J Drug Target Lahouty M, Soleymanzadeh A, Kazemi S, Saadati-Maleki H, Masoudi S, Ghasemi A, Kazemi T, Mehranfar S, Fadaee M. PMID: 40063049 [PubMed - as supplied by publisher]
	Recent advances in endoscopic diagnosis and treatment of superficial head and neck cancer. Jpn J Clin Oncol Kano K, Katada C, Furue Y, Yamashita T. PMID: 40062449 [PubMed - as supplied by publisher]
	Prognostic analysis of esophageal cancer patients after neoadjuvant therapy. Front Immunol Dong J, Li C, Wang B, Li Y, Wang S, Cui H, Gao M. PMID: 40061941 [PubMed - indexed for MEDLINE]
	Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer. Explor Target Antitumor Ther Valerio L, Matrone A. PMID: 40061140 [PubMed]
	Causes of death in locally advanced esophageal cancer undergoing neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy: a retrospective cohort study. Dis Esophagus Liu D, Liang HW, Liu Y, Huang W, Pan XB. PMID: 40059762 [PubMed - indexed for MEDLINE]
	Changes in blood pressure and metabolic factors of patients after esophagectomy assessed based on a propensity score matching approach. Support Care Cancer Yang JR, Chen XR, Xia WX, Li YX, Huang JL, Lai JB, Wang Y. PMID: 40059254 [PubMed - indexed for MEDLINE]
	Identification of biomarkers and potential drug targets for esophageal cancer: a Mendelian randomization study. Sci Rep Li C, Cui X, Ren M, Yin Y, He S. PMID: 40059241 [PubMed - indexed for MEDLINE]
	Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: an individual patient data pooled analysis of 987 patients from three prospective cohort studies. Cancer Immunol Immunother Lu Z, Sun G, Li J, Zhao J, Wang Z, Qian D, Yang Z, Li N, Wang J, Yuan S, Wang Y, Li S, Yang Z, Ran F, Ji Y, Zhu S, Zhang Y, Wang C, Wan L, Zheng R, Deng W, Cheng F, Shen L. PMID: 40056201 [PubMed - indexed for MEDLINE]
	The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma. Sci Rep Shiraishi K, Okada M, Yamamoto S, Matsubara Y, Masuishi T, Shimozaki K, Yamamoto Y, Hirose S, Sugiyama K, Furuta M, Machida N, Takahashi N, Yoshii T, Kito Y, Tsuzuki T, Boku S, Tsuchihashi K, Sugaya A, Takayama T, Komori A, Mitani S, Matsumoto T, Nishimura T, Hirata K. PMID: 40055515 [PubMed - indexed for MEDLINE]
	Clinical outcomes and short-term survival of neoadjuvant immunochemotherapy for resectable esophageal cancer: a multicenter retrospective cohort study. Int J Surg Lan K, Yan X, Lei J, Guo X, Zhou Y, Wang X, Liu H, Tian F, Lu Q, Gu Z, Sun J, Yang E, Zhong D, Wang T, Huang L, Wang J, Liu X, Ni Y, Jiang T, Zhao J. PMID: 40053810 [PubMed - indexed for MEDLINE]
	Nanoparticle-based drug delivery systems: opportunities and challenges in the treatment of esophageal squamous cell carcinoma (ESCC). Nanoscale Peng L, Gao Z, Liang Y, Guo X, Zhang Q, Cui D. PMID: 40052671 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 35785

Seite 1 von 1790

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung